Rituxan and Telaprevir

• Generic Name: rituximab
• Dosage Forms: injection, solution
• Other Brand Names: Rituxan, Truxima

Rituxan (rituximab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. It is also used to treat other non-cancer conditions.

Rituxan is an intravenous (IV) infusion given by a healthcare professional. It is a prescription medicine used alone or in combination with other medicines to treat the following conditions:

• non-Hodgkin's lymphoma or chronic lymphocytic leukemia in adults;

• rheumatoid arthritis in adults;

• granulomatosis with polyangiitis and microscopic polyangiitis (rare disorders that cause inflammation of blood vessels and other tissues in the body) in adults and children 2 years of age and older; or

• pemphigus vulgaris (a severe autoimmune reaction that causes blisters and breakdown of the skin and mucous membranes) in adults.

• Generic Name: telaprevir
• Dosage Forms: n.a.
• Other Brand Names: Incivek

Telaprevir is used in combination with injectable peginterferon alfa (Pegasys®, Pegintron®) and ribavirin (Copegus®, Rebetol®) to treat chronic hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received other medicines that did not work well. Telaprevir is an antiviral agent.

Telaprevir was available only with your doctor's prescription.

Telaprevir was withdrawn from the United States market on October 16, 2014.